Kevin Kedra Downgraded (ZTS) to Hold on, Aug 12th, 2020
Kevin has made no other calls on ZTS in the last 4 months.
There are 3 other peers that have a rating on ZTS. Out of the 3 peers that are also analyzing ZTS, 2 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Navann Ty of "Citigroup" Maintained at Hold with Increased Target to $160 on, Monday, August 10th, 2020
- Michael Ryskin of "B of A Securities" Maintained at Hold with Increased Target to $150 on, Monday, July 20th, 2020
This is the rating of the analyst that currently disagrees with Kevin
- Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $175 on, Monday, August 10th, 2020
on: Mon, Aug 10th 2020
by: WOPRAI
Naved Khan Maintained (CARG) at Strong Buy with Increased Target to $37 on, Aug 10th, 2020
on: Mon, Aug 10th 2020
by: WOPRAI
Kevin Caliendo Maintained (CAH) at Strong Buy with Decreased Target to $64 on, Aug 10th, 2020
on: Mon, Aug 10th 2020
by: WOPRAI
Michael Weinstein Maintained (CNP) at Buy with Decreased Target to $22 on, Aug 10th, 2020
on: Thu, Jul 30th 2020
by: WOPRAI
Navann Ty Maintained (ZTS) at Hold with Increased Target to $146 on, Jul 30th, 2020
on: Thu, May 07th 2020
by: WOPRAI
Balaji Prasad Maintained (ZTS) at Buy with Increased Target to $140 on, May 7th, 2020
on: Thu, Feb 13th 2020
by: WOPRAI
Sel Hardy Upgraded (ZTS) to Strong Buy and Increased Target to $160 on, Feb 13th, 2020
on: Mon, Jul 22nd 2019
by: WOPRAI
Jonathan Block Maintained (ZTS) at Strong Buy with Increased Target to $130 on, Jul 22nd, 2019
on: Mon, Jul 01st 2019
by: WOPRAI
Derik De Bruin Downgraded (ZTS) to Hold and Increased Target to $120 on, Jul 1st, 2019
on: Tue, Jun 11th 2019
by: WOPRAI
Balaji Prasad Initiated (ZTS) at Buy and Held Target at $120 on, Jun 11th, 2019
on: Wed, Aug 08th 2018
by: WOPRAI
Al Kaschalk Maintained (BECN) at Buy with Decreased Target to $50 on, Aug 8th, 2018
on: Mon, Oct 16th 2017
by: WOPRAI
on: Tue, Oct 10th 2017
by: WOPRAI
Andrew Didora Maintained (UAL) at Strong Buy with Decreased Target to $84 on, Oct 10th, 2017